Invention Grant
- Patent Title: Sustained drug delivery implant
-
Application No.: US14218324Application Date: 2014-03-18
-
Publication No.: US09610246B2Publication Date: 2017-04-04
- Inventor: Jane-Guo Shiah , Chetan Pujara
- Applicant: ALLERGAN, INC.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Laura L. Wine
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/498 ; A61F9/00
Abstract:
Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.
Public/Granted literature
- US20140234390A1 SUSTAINED DRUG DELIVERY IMPLANT Public/Granted day:2014-08-21
Information query
